Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Belmeloro, 8, 40126, Bologna, Italy.
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Clin Oral Investig. 2018 Sep;22(7):2535-2541. doi: 10.1007/s00784-018-2350-0. Epub 2018 Jan 27.
Orofacial development is a complex process subjected to failure impairing. Indeed, the cleft of the lip and/or of the palate is among the most frequent inborn malformations. The JARID2 gene has been suggested to be involved in non-syndromic cleft lip with or without cleft palate (nsCL/P) etiology. JARID2 interacts with the polycomb repressive complex 2 (PRC2) in regulating the expression patterns of developmental genes by modifying the chromatin state.
Genes coding for the PRC2 components, as well as other genes active in cell differentiation and embryonic development, were selected for a family-based association study to verify their involvement in nsCL/P. A total of 632 families from Italy and Asia participated to the study.
Evidence of allelic association was found with polymorphisms of SNAI1; in particular, the rs16995010-G allele was undertransmitted to the nsCL/P cases [P = 0.004, odds ratio = 0.69 (95% C.I. 0.54-0.89)]. However, the adjusted significance value corrected for all the performed tests was P = 0.051.
The findings emerging by the present study suggest for the first time an involvement of SNAI1 in the nsCL/P onset.
Interestingly, SNAI1 is known to promote epithelial to mesenchymal transition by repressing E-cadherin expression, but it needs an intact PRC2 to act this function. Alterations of this process could contribute to the complex etiology of nsCL/P.
口面发育是一个复杂的过程,容易受到影响而出现缺陷。事实上,唇裂和/或腭裂是最常见的先天性畸形之一。JARID2 基因被认为与非综合征性唇裂伴或不伴腭裂(nsCL/P)的病因有关。JARID2 与多梳抑制复合物 2(PRC2)相互作用,通过修饰染色质状态来调节发育基因的表达模式。
选择编码 PRC2 成分的基因以及其他在细胞分化和胚胎发育中活跃的基因进行基于家系的关联研究,以验证它们在 nsCL/P 中的参与。来自意大利和亚洲的 632 个家庭参与了这项研究。
发现 SNAI1 多态性与等位基因关联的证据;特别是,rs16995010-G 等位基因向 nsCL/P 病例的传递减少[P=0.004,优势比=0.69(95%置信区间 0.54-0.89)]。然而,经过所有进行的测试校正后,调整后的显著性值为 P=0.051。
本研究的结果首次表明 SNAI1 参与了 nsCL/P 的发病机制。
有趣的是,SNAI1 已知通过抑制 E-钙粘蛋白的表达促进上皮间质转化,但它需要完整的 PRC2 才能发挥此功能。该过程的改变可能有助于 nsCL/P 的复杂病因。